Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B
Hepatitis B virus (HBV) is a main cause of chronic liver disease worldwide and can lead to severe liver diseases. The World Health Organization has planned to eliminate viral hepatitis, including hepatitis caused by HBV and hepatitis C virus, by 2030. As mother-to-child transmission (MTCT) of HBV is...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-05-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/10/11/2320 |
| _version_ | 1797532602616250368 |
|---|---|
| author | Yoon Seok Lee Soo Min Bang Young-Sun Lee |
| author_facet | Yoon Seok Lee Soo Min Bang Young-Sun Lee |
| author_sort | Yoon Seok Lee |
| collection | DOAJ |
| description | Hepatitis B virus (HBV) is a main cause of chronic liver disease worldwide and can lead to severe liver diseases. The World Health Organization has planned to eliminate viral hepatitis, including hepatitis caused by HBV and hepatitis C virus, by 2030. As mother-to-child transmission (MTCT) of HBV is a main cause of chronic HBV infection, MTCT prevention is the main target to reduce the risk of chronic HBV infection and eliminate the disease. Recent clinical trials and meta-analyses found that antiviral therapy could prevent MTCT effectively in mothers with ≥200,000 IU/mL of HBV DNA, in combination with serial vaccination and hepatitis B immune globulin administration in infants. Despite the preventive role of antivirals for MTCT of HBV, there are several concerns regarding antiviral therapy with respect to the safety of the mother and fetus during pregnancy. This review summarizes the benefits and risks of antiviral treatment during pregnancy in women with chronic HBV infection. |
| first_indexed | 2024-03-10T11:01:37Z |
| format | Article |
| id | doaj.art-8dd66d412c614c7c931e0a3f28ce102d |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-10T11:01:37Z |
| publishDate | 2021-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-8dd66d412c614c7c931e0a3f28ce102d2023-11-21T21:26:43ZengMDPI AGJournal of Clinical Medicine2077-03832021-05-011011232010.3390/jcm10112320Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis BYoon Seok Lee0Soo Min Bang1Young-Sun Lee2Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul 08308, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul 08308, KoreaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Seoul 08308, KoreaHepatitis B virus (HBV) is a main cause of chronic liver disease worldwide and can lead to severe liver diseases. The World Health Organization has planned to eliminate viral hepatitis, including hepatitis caused by HBV and hepatitis C virus, by 2030. As mother-to-child transmission (MTCT) of HBV is a main cause of chronic HBV infection, MTCT prevention is the main target to reduce the risk of chronic HBV infection and eliminate the disease. Recent clinical trials and meta-analyses found that antiviral therapy could prevent MTCT effectively in mothers with ≥200,000 IU/mL of HBV DNA, in combination with serial vaccination and hepatitis B immune globulin administration in infants. Despite the preventive role of antivirals for MTCT of HBV, there are several concerns regarding antiviral therapy with respect to the safety of the mother and fetus during pregnancy. This review summarizes the benefits and risks of antiviral treatment during pregnancy in women with chronic HBV infection.https://www.mdpi.com/2077-0383/10/11/2320antiviralshepatitis B virusmother-to-child transmissionpregnancytenofovirsafety |
| spellingShingle | Yoon Seok Lee Soo Min Bang Young-Sun Lee Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B Journal of Clinical Medicine antivirals hepatitis B virus mother-to-child transmission pregnancy tenofovir safety |
| title | Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B |
| title_full | Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B |
| title_fullStr | Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B |
| title_full_unstemmed | Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B |
| title_short | Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B |
| title_sort | benefits and risks of antiviral treatment during pregnancy in patients with chronic hepatitis b |
| topic | antivirals hepatitis B virus mother-to-child transmission pregnancy tenofovir safety |
| url | https://www.mdpi.com/2077-0383/10/11/2320 |
| work_keys_str_mv | AT yoonseoklee benefitsandrisksofantiviraltreatmentduringpregnancyinpatientswithchronichepatitisb AT soominbang benefitsandrisksofantiviraltreatmentduringpregnancyinpatientswithchronichepatitisb AT youngsunlee benefitsandrisksofantiviraltreatmentduringpregnancyinpatientswithchronichepatitisb |